Relationships among islet cell antibodies, residual β-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: Use of a sensitive C-peptide radioimmunoassay

Metabolism

Volumn 39, Issue 9, 1990, Pages 925-930

  Nakanishi, Koji ^a,b   Kobayashi, Tetsuro ^a,b   Miyashita, Hikari ^a,b   Ohkubo, Minoru ^a,b   Sugimoto, Tadao ^a,b   Murase, Toshio ^a,b   Kosaka, Kinori ^a,b   Inouye, Ken ^a,b   Kono, Masao ^a,b  

^a Okinaka Memorial Institute for Medical Research   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; AUTOANTIBODY; BIOLOGICAL MARKER; C PEPTIDE; GLYCOSYLATED HEMOGLOBIN; PANCREAS ISLET CELL ANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET; PRIORITY JOURNAL; BLOOD; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; RADIOIMMUNOASSAY; TIME;

AUTOANTIBODIES; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, INSULIN-DEPENDENT; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMAN; ISLETS OF LANGERHANS; MALE; MIDDLE AGE; RADIOIMMUNOASSAY; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0025485559     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/0026-0495(90)90302-S     Document Type: Article

References (33)

1. Risk factors for progression of diabetic retinopathy in patients with insulin-dependent diabetes mellitus
2. The relationship between residual insulin secretion and metabolic stability in type 1 (insulin dependent) diabetes
3. Correlation between minimal secretory capacity of pancreatic β-cells and stability of diabetic control
4. Prevalence of residual β-cell function in insulin-treated diabetics evaluated by the plasma C-peptide response to intravenous glucagon
5. Beta-cell function and metabolic control in insulin treated diabetics
6. Effects of age duration and treatment of insulin-dependent diabetes mellitus on residual β-cell function Observations during eligibility testing for the diabetes control and complications trial (DCCT)
7. Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirement
8. Studies on the etiology of “brittle diabetes”: Relationship between diabetic instability and insulinogenic reserve
9. Metabolic control in diabetic patients: Effect of insulin-secretory reserve (measured by plasma C-peptide levels) and circulating insulin antibodies
10. Prevalence of residual β cell function and its metabolic consequences in type 1 (insulin-dependent) diabetes
11. Islet function in diabetics with persistent islet cell antibodies
12. Islet-cell antibodies and beta-cell function in insulin-dependent diabetics
13. Islet cell surface antibodies (ICSA) in relation to symptoms at onset and early remission in juvenile
14. The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method
15. Time course of islet cell antibodies and β-cell function in non-insulin-dependent stage of type I diabetes
16. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
17. 131I-labeled human growth hormone of high specific radioactivity
18. Radioimmunoassay for human proinsulin C-peptide
19. Immunology and diabetes workshop: Report on the third international (stage 3) workshop on the standardization of cytoplasmic islet cell antibodies
20. 1c: A rapid, automated precision-chromatography technique
21. Type 1 diabetes mellitus. A chronic autoimmune disease
22. Natural history of type 1 diabetes and slowly progressive IDDM
23. Histopathological changes of the pancreas in islet cell antibodies (ICA)-positive subjects before and after the clinical onset of insulin-dependent diabetes mellitus (IDDM)
24. Inverse relationship between residual beta-cells and exocrine pancreas in insulin-dependent diabetics
25. β-cell function of insulin-dependent young onset diabetics assessed by C-peptide immunoreactivity
26. Evaluation of three commercially available C-peptide kits
27. Characterization of the residual beta-cell function in diabetics by a new C-peptide radioimmunoassay
28. Radioimmunoassay of ACTH in plasma
29. Radioimmunological determination of human C-peptide in serum
30. Meal-stimulated C-peptide and insulin antibodies in type 1 diabetic subjects and their nondiabetic siblings characterized by HLA-DR antigens
31. Genetics of insulin-dependent diabetes
32. Maleness as risk factor for slowly progressive IDDM